Bullboard Post History

by Capitalista

Order by:

T.ONC	RE:RE:Radio ad location ⬇️ Too many posts here about something inconsequential. The sponsorship... November 2, 2023
T.ONC	RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023 Thanks, Azzak. I wonder why ESMO has a 10-month cutoff - this seems... October 16, 2023
T.ONC	RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023 Am I missing something here? The data cutoff for ESMO is listed as 19... October 16, 2023
T.ONC	RE:RE:Deal or no deal! I think a buyout at ANY price is many months away. ONCY is just not... October 3, 2023
T.ONC	RE:RE:RE:RE:Reality Check The one thing I gleaned from ONC/Y’s recent public offering is that they... August 9, 2023
T.ONC	RE:Promising Pathways Act (PPA) The PPA bill could be huge for ONC/Y. I'll have to read the bill to... July 9, 2023
T.ONC	Article on SeekingAlpha.com There's an article on ONC/Y on SeekingAlpha.com. I just dropped my... July 4, 2023
T.ONC	RE:RE:RE:RE:RE:RE:RE:RE:RE:ONC You're right, jimsenior. I'll take your advice. June 28, 2023
T.ONC	RE:RE:RE:RE:RE:RE:RE:ONC Specious? I think not. Can you justify that comment? Or, in your own... June 28, 2023
T.ONC	RE:RE:RE:RE:ONC Noteable: For the ATM activity, please refer to ONC’s 2022 year-end... June 28, 2023
T.ONC	RE:RE:ONC My faith is mainly in the science as well. I would describe my attitude... June 27, 2023
T.ONC	RE:I Only Have One Word As they say in South America: "tener fe!" June 27, 2023
T.ONC	RE:ONCY pelareorep selected for Phase 3 Pancreatic Cancer trial This is huge! PanCAN is the sponsor, so this allows ONC... June 22, 2023
T.ONC	RE:RE:RE:RE:RE:RE:AA and mBC Noteable, in which subset of HR+ HER- mBC treatment situations are you saying... June 19, 2023
T.ONC	RE:RE:RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela Thanks, jimsenior - I'm happy to say I'm the one who stands corrected... June 2, 2023
T.ONC	RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela The text in the abstract is confusing - they use future tense ("... June 2, 2023
T.ONC	RE:RE:RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out Noteable, I'd say that Pfizer buying Trillium was the catalyst that drove... May 16, 2023
T.ONC	RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out Agreed, fox7mf. I doubt that we'll see anything more than a several... May 16, 2023
T.ONC	RE:RE:RE:ONC/Y and the FDA venture009 wrote: An AA is something we would all like but I don't think... April 4, 2023
T.ONC	ONC/Y and the FDA Like most, I am concerned about both the complete lack of info on potential... April 3, 2023

Become a member today, It's free!

Bullboard Post History

by Capitalista

RE:RE:Radio ad location ⬇️

RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023

RE:New Press Release - Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023

RE:RE:Deal or no deal!

RE:RE:RE:RE:Reality Check

RE:Promising Pathways Act (PPA)

Article on SeekingAlpha.com

RE:RE:RE:RE:RE:RE:RE:RE:RE:ONC

RE:RE:RE:RE:RE:RE:RE:ONC

RE:RE:RE:RE:ONC

RE:RE:ONC

RE:I Only Have One Word

RE:ONCY pelareorep selected for Phase 3 Pancreatic Cancer trial

RE:RE:RE:RE:RE:RE:AA and mBC

RE:RE:RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

RE:RE:RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out

RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out

RE:RE:RE:ONC/Y and the FDA

ONC/Y and the FDA

Featured Company

Desert Gold Ventures Inc. V.DAU

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Capitalista

Featured Company